banner add

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.

from NYT > Health https://ift.tt/GlCyOR1
via IFTTT

No comments

Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. from NYT > H...

Theme images by PLAINVIEW. Powered by Blogger.